SXDPEX:SW:SW-iShares STOXX Europe 600 Health Care UCITS ETF (DE) EUR (EUR)

ETF | Others |

Last Closing

USD 118.68

Change

0.00 (0.00)%

Market Cap

USD 0.44B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

-0.02 (-0.15%)

USD 1,244,681.59B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

-0.02 (-0.10%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.31 (+1.15%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

+82.00 (+1.03%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+56.00 (+1.06%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+6.80 (+0.41%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+10.00 (+0.47%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

+0.17 (+0.22%)

USD 131,872.43B
SPMCHA:SW UBS ETF (CH) – SPI® Mid (CH..

+0.12 (+0.11%)

USD 130,595.12B

ETFs Containing SXDPEX:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.37% 65% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.37% 65% D 65% D
Trailing 12 Months  
Capital Gain 11.54% 48% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.54% 47% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.07% 55% F 56% F
Dividend Return 4.07% 55% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.26% 64% D 68% D+
Risk Adjusted Return 77.40% 69% C- 72% C
Market Capitalization 0.44B 55% F 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike